CD36 serves as a signaling receptor and free fatty acid (FFA) transporter in dyslipidemia: the role of dapagliflozin and alirocumab in downregulating atherogenic dyslipidemia via FFA uptake inhibition—experimental studyJui‐Ning Yeh, Jun Guo, Chi‐Ruei Huang et al.|International Journal of Surgery|2025Cited by 3
Nanog overexpression enhances the therapeutic efficacy of ADMSCs in AMI rats via the upregulation of JAK/STAT3 signaling and cyclin-mitochondrial expressionHsu-Ting Yen, Sheung‐Fat Ko, Di Huang et al.|International Journal of Biological Sciences|2025Cited by 2
Alirocumab therapy effectively suppresses colorectal cancer cell growth and invasion in nude mouse liver – PCSK9 is a key driver of PI3K/Akt/p-Bad-mediated cell proliferation and antiapoptotic signalingJui‐Ning Yeh, Hon-Kan Yip, Jun Guo et al.|International Journal of Surgery|2025Cited by 0